Millennium Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.5M | Sell |
198,110
-19,269
| -9% | -$1.22M | 0.01% | 1448 |
|
2025
Q1 | $11.5M | Buy |
217,379
+202,120
| +1,325% | +$10.7M | 0.01% | 1420 |
|
2024
Q4 | $854K | Sell |
15,259
-21,718
| -59% | -$1.22M | ﹤0.01% | 2979 |
|
2024
Q3 | $1.94M | Buy |
+36,977
| New | +$1.94M | ﹤0.01% | 2563 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 4422 |
|
2024
Q1 | – | Sell |
-34,831
| Closed | -$1.6M | – | 4481 |
|
2023
Q4 | $1.6M | Sell |
34,831
-3,941
| -10% | -$181K | ﹤0.01% | 2579 |
|
2023
Q3 | $889K | Buy |
+38,772
| New | +$889K | ﹤0.01% | 2970 |
|
2023
Q2 | – | Sell |
-546,906
| Closed | -$9.76M | – | 4680 |
|
2023
Q1 | $9.76M | Buy |
546,906
+504,608
| +1,193% | +$9M | 0.01% | 1448 |
|
2022
Q4 | $1.23M | Buy |
+42,298
| New | +$1.23M | ﹤0.01% | 3002 |
|
2022
Q3 | – | Sell |
-489,121
| Closed | -$2.03M | – | 5466 |
|
2022
Q2 | $2.03M | Buy |
489,121
+128,529
| +36% | +$533K | ﹤0.01% | 2884 |
|
2022
Q1 | $4.15M | Buy |
360,592
+46,888
| +15% | +$540K | ﹤0.01% | 2449 |
|
2021
Q4 | $3.13M | Buy |
313,704
+96,780
| +45% | +$966K | ﹤0.01% | 2600 |
|
2021
Q3 | $2.83M | Buy |
216,924
+60,108
| +38% | +$785K | ﹤0.01% | 2714 |
|
2021
Q2 | $3.07M | Sell |
156,816
-13,711
| -8% | -$268K | ﹤0.01% | 2680 |
|
2021
Q1 | $3.63M | Buy |
+170,527
| New | +$3.63M | ﹤0.01% | 2363 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 4342 |
|
2020
Q1 | – | Sell |
-22,273
| Closed | -$511K | – | 3573 |
|
2019
Q4 | $511K | Sell |
22,273
-218,155
| -91% | -$5.01M | ﹤0.01% | 2741 |
|
2019
Q3 | $5.19M | Buy |
240,428
+220,573
| +1,111% | +$4.76M | 0.01% | 1438 |
|
2019
Q2 | $437K | Buy |
19,855
+11,678
| +143% | +$257K | ﹤0.01% | 2823 |
|
2019
Q1 | $224K | Buy |
+8,177
| New | +$224K | ﹤0.01% | 3149 |
|
2018
Q4 | – | Sell |
-19,194
| Closed | -$560K | – | 3647 |
|
2018
Q3 | $560K | Sell |
19,194
-9,308
| -33% | -$272K | ﹤0.01% | 2821 |
|
2018
Q2 | $891K | Buy |
+28,502
| New | +$891K | ﹤0.01% | 2573 |
|